1. Home
  2. BTMD

as 04-10-2025 11:32am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.

;SMA (50)$4.18EMA (200)$5.23O: $3.44 H: $3.58 L: $3.37 C: $3.37 −0.07 (−2.18%)Elder Ray 0.12, −0.10
Founded: 2012 Country:
United States
United States
Employees: N/A City: IRVING
Market Cap: 136.0M IPO Year: N/A
Target Price: $8.00 AVG Volume (30 days): 327.8K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.09 EPS Growth: -30.22
52 Week Low/High: $3.04 - $8.44 Next Earning Date: 05-06-2025
Revenue: $197,191,000 Revenue Growth: 6.38%
Revenue Growth (this year): 6.2% Revenue Growth (next year): 9.24%

BTMD Daily Stock ML Predictions

SELLHOLDBUYas of 2 hours ago

Stock Insider Trading Activity of Biote Corp. (BTMD)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
HEYER ANDREW R BTMD Director Mar 17 '25 Buy $3.95 75,000 $296,042.50 1,523,513
Cone Stephen Mark BTMD Director Mar 17 '25 Buy $3.88 38,104 $147,843.52 160,829
Christensen Bret BTMD Chief Executive Officer Mar 17 '25 Buy $3.87 37,595 $145,492.65 37,595
Guines LLC BTMD 10% Owner Mar 13 '25 Buy $3.48 1,713,218 $5,568,838.51 3,927,447

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use